CSIMarket
 

Veracyte inc   (VCYT)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Veracyte Inc 's Working Capital Per Sales

VCYT's Working Capital and Revenue growth



VCYT Working Capital Per Revenue (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Working Capital Change 20.13 % 17.63 % 13.52 % 9.27 % 2.93 %
Y / Y Revenue Change 22.29 % 19.2 % 23.96 % 21.6 % 19.25 %
Working Capital Per Revenue 0.6 0.6 0.6 0.62 0.63
Total Ranking # 1252 # 1905 # 2400 # 1114 # 1222
Seq. Working Capital Change 4.69 % 5.96 % 3.42 % 4.71 % 2.51 %
Seq. Revenue Change 8.98 % -0.24 % 9.58 % 2.65 % 6.22 %





Comment on VCYT's Working Capital Per Revenue in the fourth quarter 2023
Working Capital Per Revenue remained unchanged in the fourth quarter 2023 relative to previous quarter at 0.6

Within Healthcare sector 15 other companies have achieved lower Working Capital Per Revenue during the Q4 2023. While Veracyte Inc Working Capital Per Revenue overall ranking has impoved so far in the Q4 2023 to 1252, from total ranking in the third quarter 2023 at 1905.
Working Capital Per Revenue Ranking
Within: No.
Industry # 3
Sector # 16
S&P 500 # 1252


Working Capital Per Revenue Statistics
High Average Low
2.45
0.97
0.49
(Mar 31 2021)   (Jun 30 2018)



Financial Statements
Veracyte Inc 's Working Capital $ 231 Millions Visit VCYT's Balance sheet
Veracyte Inc 's Revenues $ 98 Millions Visit VCYT's Income Statement
Where are VCYT's Sales coming from? Visit VCYT's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Dec 31 2023, within Healthcare Sector Working Capital Per Revenue
The Beauty Health Company  1.61 
Inmode Ltd   1.59 
Biomerica Inc   1.56 
Neuroone Medical Technologies Corporation  1.52 
Argenx se  1.48 
Inmed Pharmaceuticals Inc   1.45 
Clearpoint Neuro Inc   1.41 
Twist Bioscience Corporation  1.40 
Intra cellular Therapies Inc   1.28 
Urogen Pharma Ltd   1.27 
Si bone inc   1.24 
Orthopediatrics Corp  1.23 
Olink Holding Ab publ   1.23 
G1 Therapeutics Inc   1.23 
United Therapeutics Corporation  1.20 
Silk Road Medical Inc   1.19 
Biocryst Pharmaceuticals Inc   1.19 
Revance Therapeutics Inc   1.18 
Beigene ltd   1.18 
Axonics Inc   1.17 
Regeneron Pharmaceuticals Inc   1.12 
Fonar Corporation  1.10 
Castle Biosciences Inc   1.10 
Astrazeneca Plc  1.09 
Moderna Inc   1.09 
Glaukos Corp  1.07 
Nuwellis Inc   1.07 
Vertex Pharmaceuticals Inc  1.07 
Alnylam Pharmaceuticals Inc   1.05 
Tela Bio Inc   1.04 
Date modified: 2024-03-01T04:53:04+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com